111 Capital’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
111 Capital's DXCM Position: Q2 2026 in Review
111 Capital increased its DexCom (DXCM) stake by 118% in Q2 2026, buying an estimated $268K and bringing the position to 7,430 shares worth $500K. The position accounts for 0.09% of the portfolio, ranked #237.
111 Capital first reported a position in DXCM in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.75M in Q3 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- 111 Capital held 7,430 shares of DexCom worth $500K as of Q2 2026.
- 111 Capital bought 4,026 DexCom shares in Q2 2026, an estimated $268K.
- DexCom made up 0.09% of 111 Capital's portfolio in Q2 2026, its #237 holding.
- 111 Capital first reported a position in DexCom in Q1 2025 and has held it in 5 quarters since.
- 111 Capital's DexCom position peaked at $1.75M in Q3 2025.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.